Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Change in Accured Expenses (2016 - 2025)

INVO Fertility (IVF) has disclosed Change in Accured Expenses for 15 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • Quarterly Change in Accured Expenses rose 16337.84% to $1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Sep 2025, up 295.61% year-over-year, with the annual reading at $1.4 million for FY2024, 696.15% up from the prior year.
  • Change in Accured Expenses for Q3 2025 was $1.1 million at INVO Fertility, up from -$743311.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $1.4 million in Q4 2024, with the low at -$743311.0 in Q2 2025.
  • Average Change in Accured Expenses over 5 years is $113329.5, with a median of $33028.0 recorded in 2021.
  • Peak annual rise in Change in Accured Expenses hit 16337.84% in 2025, while the deepest fall reached 683.81% in 2025.
  • Over 5 years, Change in Accured Expenses stood at -$13890.0 in 2021, then skyrocketed by 4836.67% to $657924.0 in 2022, then crashed by 206.94% to -$703570.0 in 2023, then skyrocketed by 303.66% to $1.4 million in 2024, then fell by 22.94% to $1.1 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $1.1 million, -$743311.0, and -$256689.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.